Antibody therapy for rheumatoid arthritis.
High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to pro...
Autor principal: | Taylor, P |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2003
|
Ítems similars
-
Humanised monoclonal antibody therapy for rheumatoid arthritis.
per: Isaacs, J, et al.
Publicat: (1992) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
per: Isaacs, J, et al.
Publicat: (1992) -
Anti-cytokine therapy for rheumatoid arthritis.
per: Maini, R, et al.
Publicat: (2000) -
Anti-TNFalpha therapy for rheumatoid arthritis: an update.
per: Taylor, P
Publicat: (2003) -
Antikeratin antibodies in rheumatoid arthritis
per: J Zabek
Publicat: (2003-02-01)